[1]党颖慧,陈 柳,袁 静,等.TCT和HPV在HSIL及宫颈癌患者中的应用分析[J].医学信息,2022,35(18):138-140.[doi:10.3969/j.issn.1006-1959.2022.18.038]
　DANG Ying-hui,CHEN Liu,YUAN Jing,et al.Application of TCT and HPV in HSIL and Cervical Cancer Patients[J].Journal of Medical Information,2022,35(18):138-140.[doi:10.3969/j.issn.1006-1959.2022.18.038]
点击复制

TCT和HPV在HSIL及宫颈癌患者中的应用分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年18期
页码:
138-140
栏目:
诊疗技术
出版日期:
2022-09-15

文章信息/Info

Title:
Application of TCT and HPV in HSIL and Cervical Cancer Patients
文章编号:
1006-1959（2022）18-0138-03
作者:
党颖慧; 陈 柳; 袁 静; 等
（空军军医大学第一附属医院妇产科，陕西 西安 710032）
Author(s):
DANG Ying-hui; CHEN Liu; YUAN Jing; et al.
(Department of Obstetrics and Gynecology,the First Affiliated Hospital of Air Force Medical University,Xi’an 710032,Shaanxi,China)
关键词:
液基细胞学检测; 人乳头状瘤病毒检测; 高级别鳞状上皮内病变; 宫颈癌
Keywords:
Thinprep cytologic test; Human papillomavirus; High-grade squamous intraepithelial lesion; Cervical cancer
分类号:
R446
DOI:
10.3969/j.issn.1006-1959.2022.18.038
文献标志码:
A
摘要:
目的 研究宫颈液基细胞学检测（TCT）及人乳头状瘤病毒（HPV）检测在高级别鳞状上皮内病变（HSIL）及宫颈癌早期筛查中的临床意义。方法 选取2020年3月-2021年8月空军军医大学第一附属医院经病理诊断为HSIL和宫颈癌的268例患者作为研究对象，均行HPV、TCT及宫颈组织活检，以病理诊断为金标准，对TCT及HPV检测结果进行分析。结果 268例患者中病理诊断为HSIL共238例，宫颈鳞癌28例，宫颈腺癌2例。268例患者中TCT检查结果阳性率为89.93%，以HSIL为主，其次是LSIL；5例患者TCT结果为AGC，但是病理结果均为HSIL，而2例腺癌患者TCT结果为ASCUS。HPV检测结果阳性率为96.64%，阳性率从高到低前6种亚型为HPV16、58、52、18、33、31。结论 TCT与HPV在检测HSIL及宫颈癌中均具有重要作用，开展早期联合筛查可减少HSIL和宫颈癌的漏诊率。
Abstract:
Objective To study the clinical significance of thinprep cytologic test (TCT) and human papillomavirus (HPV) detection in early screening of high-grade squamous intraepithelial lesion (HSIL) and cervical cancer.Methods A total of 268 patients who were pathologically diagnosed as HSIL and cervical cancer in the First Affiliated Hospital of Air Force Medical University from March 2020 to August 2021 were selected as the study subjects. All patients underwent HPV, TCT and cervical biopsy. TCT and HPV test results were analyzed with pathological diagnosis as the gold standard.Results Of the 268 patients, 238 were pathologically diagnosed as HSIL, 28 were cervical squamous cell carcinoma, and 2 were cervical adenocarcinoma. The positive rate of TCT in 268 patients was 89.93%, mainly HSIL, followed by LSIL; TCT results of 5 patients were AGC, but the pathological results were HSIL, while TCT results of 2 patients with adenocarcinoma were ASCUS. The positive rate of HPV test results was 96.64%, and the positive rate from high to low was HPV16, 58, 52, 18, 33, 31.Conclusion TCT and HPV play an important role in the detection of HSIL and cervical cancer. Early combined screening can reduce the missed diagnosis rate of HSIL and cervical cancer.

参考文献/References:

[1]杨飞翔,江俊青,罗克锴,等.HPV-DNA及TCT检测在宫颈癌早期诊断中的应用[J].医学研究杂志,2020,49(11):87-90,103.[2]Balmagambetova S,Gabutti G,Koyshybaev A,et al.Cervical screening in Western Kazakhstan: liquid-based cytology ‘Cell Scan’versus azur-eosin staining[J].J Med Screen,2020,27(2):90-95. [3]Saito Y,Favorov AV,Forman M,et al.Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma[J].Head Neck,2020,42(4):688-697. [4]尹莉,杨晓荣,喻永林,等.HPVE6/E7mRNA检测联合TCT在宫颈癌及癌前病变筛查中的临床意义[J].遵义医科大学学报,2020,43(6):753-758[5]杨敏.美国最新子宫颈癌筛查指南的介绍[J].中华妇产科杂志,2013,48(5):394-396.[6]魏爱婷,王富伟.液基薄层细胞学技术联合HPV DNA检测在诊断高级别宫颈病变中的临床价值[J].齐齐哈尔医学院学报,2021,42(11):965-968.[7]杨怡卓,李亚里,徐滨,等.TCT在宫颈病变筛查中的临床价值及不足[J].中国妇产科临床杂志,2008,9(2):87-89.[8]陶志梅,潘敏,俞美娟,等.高危型人乳头瘤病毒感染联合液基薄层细胞检测对宫颈癌及宫颈癌前病变筛查与随访的临床意义[J].中华医院感染学杂志,2017,27(10):2340-2343.[9]罗媛华.基于TCT、HPV基因分型与DNA定量检测的宫颈癌及癌前病变筛查方法[J].解放军预防医学杂志,2020,38(3):84-87.[10]李霞,黄一授.TCT联合高危型HPV基因检测对疑似宫颈癌患者的评估价值分析[J].现代诊断与治疗,2021,32(9):1349-1351.[11]邵玮,李敬巍.宫颈薄层液基细胞学联合高危型人乳头瘤病毒检测对老年宫颈癌前病变及宫颈癌的诊断价值分析[J].老年医学与保健,2020,26(4):618-621.[12]陶祥,郑宝文,赵澄泉.子宫颈细胞学和高危型人乳头瘤病毒感染多中心临床资料分析[J].中国妇产科临床杂志,2018,19(2):187-189.[13]Malik H,Khan FH,Ahsan H.Human papillomavirus: current status and issues of vaccination[J].Arch Virol,2014,159(2):199-205.[14]Clifford GM,Callus S,Herrero R,et al.Worldwide distribution of human papillomarivus types in cytologically normal women in the International Agency for Reserch on Cancer HPV prevalence surveys: a pooled analysis[J].Lancet,2005,366(9490):991-998.[15]王开昕,王晶,雷立容.宫颈病变的液基细胞学与病理学检查结果对照分析[J].中国医药导刊,2014,16(4):724-725.[16]钟建容,禹良,靳化,等.TCT联合HPV检测在妊娠期宫颈癌筛查中的作用及结果分析[J].生殖医学杂志,2021,30(12):1564-1568.[17]薛雯娣,宫美丽,李旭,等.高级别宫颈上皮内瘤变及宫颈癌患者宫颈液基薄层细胞学检查和高危型人乳头状瘤病毒检测结果分析[J].中国药物与临床,2021,21(3):492-494.

更新日期/Last Update: 1900-01-01